Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Pediatrics in Review. 1980;2:87.)
© 1980 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Asthma Treatment

In the April issue of PIR (1:301, 1980) in the article "Pharmacologic Management of Childhood Asthma," two corrections should be made: (1) In Table 2 (p 303) the maximum dose for epinephrine and Bronkephrine is listed as 0.5 ml. It should be 0.3 ml as stated in the text. (2) In Table 4 (p 304) the sustained release theophylline preparations are noted with an asterisk (*); they should be indicated by a double dagger (Dagger). Please change the symbols from * to Dagger in the Table.






HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics Pediatrics in Review
Copyright © 1980 by the American Academy of Pediatrics.